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Lichen Planus (LP) is a chronic disease that affects the skin and oral mucosa. Although the precise 
aetiology of LP is not known, it is thought to be comprised of, in majority, genetic and immunological 
factors. The objective of this study was to assess the association of interleukin-17A (IL-17A) with Oral 
LP (OLP). 22 adult patients with OLP and 40 healthy controls were genotyped by polymerase chain 
reaction (PCR) and DNA direct sequence technology for the polymorphism of the IL-17A gene. The 
genotype frequencies of G1776A (p.Arg29Ter rs139620979) and G3566A (rs7747909) in the IL-17A gene 
polymorphism were 9 and 13.6% in the OLP group and 0 and 40% in the controls, respectively. 
Although the proportion of detected polymorphisms did not differ between individuals, a higher 
prevalence of G3566A (rs7747909) homozygote polymorphism (4.5%) was observed in the OLP patients. 
Our results show no statistically significant difference in the IL-17A genotype single nucleotide 
polymorphisms (SNPs) distribution amongst the two groups. Therefore, further studies on a larger 
population and novel genetic variants are needed to better understand the pathobiology of OLP. 
 






Lichen Planus (LP) is a common inflammatory disease of 
the skin and oral mucosa, commonly found by dentists 
during routine checkups (Agha-Hosseini et al., 2010). 
Affecting around 1 to 2% of the general population in the 
US, approximately one in five people with Oral LP (OLP) 
have comorbid skin LP (Habif, 2009; Mirowski and Mark, 
2010), with severe forms causing painful sores and ulcers 
(Pavlotsky, 2008). 
To follow on, oral lesions which are most commonly 
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characterized by white or grey streaks, forming a linear or 
reticular pattern on a violaceous background. These 
lesions are classified as reticular, plaque like, atrophic, 
popular, erosive or bulbous (Chuang et al., 1999; Bigby, 
2009). 
Furthermore, there is a slight increased risk of 
developing oral cancer in severe cases of LP, in 
particular when the disease state involves the dorsal 
aspect of the tongue (Agha-Hosseini et al., 2010; 
Pavlotsky, 2008). However, this observation may be 
confounded by other factors, such as smoking or chewing 
tobacco (Chuang et al., 1999; Bigby, 2009). Despite this, 
several studies have highlighted the malignant 






The precise understanding of the etiology of LP is in 
the majority, unknown or incomplete. However, it is likely 
to be related to an allergic or immune reaction, or a viral 
or bacterial infection (Bhattacharya et al., 2000; Norris, 
1990). Some patients with LP have a positive familial 
history, thus, LP may be influenced by a genetic 
predisposition (Chuang et al., 1999; Bigby, 2009). In 
addition, the role of the immune system is confirmed by 
the histopathologic appearance of the disease with linear 
sub-basilar T lymphocytic infiltration, macrophages and 
basal layer degeneration. These findings can be 
interpreted as a demonstration of the role of cell-
mediated immunity in the pathogenesis of OLP. To follow 
on, this presentation is created by T cytotoxic 
lymphocytes, directly produced against the antigen in the 
basal cell layer (Shengyuan et al., 2009; Bhattacharyya, 
1999). T-helper 17 (Th17) cells are a lineage of CD4
+
T 
cells, characterized by their production of interleukin-17 
(IL-17) (Fouser et al., 2008). IL-17A (OMIM: 603149) was 
cloned more than 10 years ago (Figure 1), with six IL-17A 
family members (IL-17A-F) subsequently having been 
described (Kolls and Lindén, 2004). These findings have 
helped accumulate support for the role of Th17A cells 
and such cytokines in inflammatory processes and 
autoimmunity or inflammation found in animal models. 
Polymorphisms of IL-17A, G197A (rs2275913) and IL-
17F A7488G (p.His161Arg rs763780) have recently been 
identified as being associated with a susceptibility to 
rheumatoid arthritis and ulcerative colitis. Emerging data 
in clinical trials support our understanding of the 
importance of Th17 cells in inflammatory disease (Fouser 
et al., 2008). In addition, some studies have shown that 
IL-17A plays a crucial role in chronic infection by means 
of several mechanisms (Kolls and Lindén, 2004). 
Moreover, there is current experimental and clinical 
evidence to illustrate that IL-17 family members are 
involved in specific inflammatory processes leading to the 
mobilization of granulocytes. To date, most published 
evidence supports a role for IL-17A, and possibly IL-17F, 
as a promoter of granulopoeisis, neutrophil accumulation 
and neutrophil activation in the lungs, joint space, central 
nervous system and intestinal tissue (Kolls and Lindén, 
2004). Due to the importance of LP as a chronic condition 
with an unknown etiology thought to be involving 
immunological factors in its progression , we used direct 
sequencing to study the possible changes in the DNA 
structure, which allows for the independent evaluation of 
the role of IL-17A in LP. 
 
 




The study population consisted of those who were referred to the 
Department of Oral Medicine, Tabriz University of Medical 
Sciences. The Ethics Committee of Tabriz University of Medical 
Sciences approved the study protocol, with written informed 
consent obtained from all of the participating subjects. Twenty-two 




(22) patients were selected from those with the diagnosis of OLP, 
which was confirmed by a biopsy. All of the patients were between 
the ages of 18 to 60 years and willing to participate in the study. 
None of the patients had any potential cause for a lichenoid 
reaction. In addition, none of the subjects had any congenital or 
acquired cause for an immune system deficiency such as Acquired 
Immunodeficiency Syndrome (AIDS), chemotherapy, IV drug 
addiction, hemophilia or undergoing dialysis. Also, none of the 
patients were on medication such as anti-inflammatory drugs, or 
had active infections such as hepatitis, human immunodeficiency 
virus infection (HIV) or tuberculosis. The subjects were not pregnant 
at the time of the study and were not using calcium channel 
blockers. The selected group did not receive medical intervention, 
so there were no side effects to the treatment. 40 individuals with 
no history of any oral inflammation were selected as a healthy 





Genomic DNA extraction was performed from 5cc peripheral blood 
samples with ethylene diamine tetra acetic acid (EDTA) using the 
salting out method. 
 
 
Exon amplification and genotyping of polymorphisms 
 
The polymorphisms were genotyped using the direct sequencing 
method, with three exons of the IL-17A gene and their flanking 
intronic sequences amplified from genomic DNA. The polymerase 
chain reaction (PCR) used the following primers: Forward, 5’- 
CCATCTCATAGCAGGCACAA-3` and Reverse, 5’- 
CCAAAGCTTTCATTTCCTATCCT-3`(exon 1); Forward, 5’- 
TGAGAACAATGGTGCAGGAG-3` and Reverse, 5’- 
CACAGTGGTCCTTCCAGGTT-3`(exon 2); Forward, 5’- 
TCCTCCTGATTTTTCTCCCC-3` and  Reverse, 5’- 
ATTCCCAAGCCCAGAATCTT-3` (exon 3). The 25 ul reactions 
were carried out under standard conditions, containing 100 to 200 
ng of genomic DNA, 12.5 ul of master mix (Ampliqon), 1 mm each 
of forward and reverse primers and 5 ul of H2O. The PCR 
procedure was as follows: an initial denaturation at 95°C for 5 min 
followed by 35 cycles of denaturation at 95°C (45 s), annealing at 
62°C (45 s) and extension at 72°C (3 min), with a final 10 min 
extension at 72°C. 
The PCR fragments were separated by electrophoresis, 
composing of 1.5% agarose gel containing ethidium bromide and 
visualized by ultraviolet illumination. PCR products were purified 
using a PCR Purification Kit (Core Bio, Korea). The sequencing and 
analysis of the reactions were then carried out by Macrogen 
(Korea). DNA sequencing was performed in both directions, 
initiated from the forward and reverse primers used in the initial 





The distribution of the genotype and alleles between patients and 
healthy controls were compared using the χ
2
 test. A binary logistic 
regression analysis was used to assess the influence of gender, 
age and smoking on the association of IL-17A polymorphisms with 
OLP. Statistical analyses were performed using SPSS 15.0 





The study case group consisted of 14 males and eight




Table 1. Demographics and characteristics of clinical features in OLP patients. 
 
Category Variable Case group number (%) Control group number (%) 
Sex 
Male 14(63) 25(62.5) 
Female 8(27) 15(37.5) 
    
Cigarette smoking 
Male 6(27.2) 12(30) 




Table 2. The frequency of polymorphisms in the case and control groups. 
 
SNP Site Genotype ‍Case (%) Control (%) 
T569A  Exon1 Heterozygote 2(4.5) 0 
G591A  Exon1 Heterozygote 2(4.5) 0 
G1776A (p.Arg29Ter rs139620979) Exon2 Heterozygote 4(9) 0 
G1663A Exon2 Heterozygote 1(2.2) 0 
G1578A  Exon2 Heterozygote 2(4.5) 0 
T1677A  Exon2 Heterozygote 1(2.2) 0 
C3444G  Exon3 Heterozygote 1(2.2) 0 
G3566A (rs7747909)  Exon3 Homozygote 2(4.5) 0 
G3566A (rs7747909)   Exon3 Heterozygote 6(13.6) 16(40) 




females, whilst the control group consisted of 25 males 
and 15 females. The mean ages of the case and control 
groups were 41 and 43 years respectively. There were no 
significant differences between the case and control 
groups with respect to age and gender. The clinical 
characteristics of the study subjects are summarized and 
shown in Table 1. 
 
 
Molecular evaluation and association of IL-17A gene 
polymorphisms with OLP 
 
The three exons of the IL-17A gene and their flanking 
intronic sequences were amplified from the extracted 
genomic DNA samples of the OLP subjects and the 
healthy controls. These were then genotyped by the 
direct sequencing method. The distribution of the 
polymorphisms detected in the IL-17A gene on the 44 
chromosomes of cases and 80 chromosomes of controls 
examined are shown in Table 2 and Figures 2 and 3. 
The polymorphisms G1776A (p.Arg29Ter 
rs139620979) in exon 2 and G3566A (rs7747909) in 
exon 3 were more prevalent, respectively. The overall 
predominant polymorphism was G3566A (rs7747909), 
which was found homozygote on 2% of alleles of OLP 
patients but not in the control group. 
 
 
Genotypes and phenotype-genotype correlation 
 
We compared the clinical phenotypes between genotypic 
groups to determine whether the presence of a 
polymorphism in an OLP patient was associated with 
more severe manifestations of the disease. No significant 
difference was found between the clinical characteristics 
of those patients with OLP who did not have the IL-7A 
polymorphism detected, with those who did (p ˂ 0.05). 
Although the proportions of detected polymorphisms did 
not differ between the patients with OLP and the control 
group (p ˂ 0.05), a higher prevalence of G3566A 
(rs7747909) homozygote polymorphism was observed in 





In this study, we attempted to detect an association 
between the single nucleotide polymorphisms (SNPs) of 
IL-17A with OLP, in a northwest Iranian population. We 
chose the IL-17A gene as a candidate based 
predominantly on its recently reported important role in 
inflammation. The protein encoded by the IL-17A gene is 
a pro-inflammatory cytokine produced by activated T 
cells. This cytokine regulates the activities of NF-kappaB 
and mitogen-activated protein kinases. This cytokine can 
stimulate the expression of IL-6 and cyclooxygenase-2 
(PTGS2/COX-2), as well as enhance the production of 
nitric oxide (NO). High levels of this cytokine are 
associated with several chronic inflammatory diseases 
including rheumatoid arthritis, psoriasis and multiple 
sclerosis (Fouser et al., 2008; Kolls and Lindén, 2004).






Figure 1. IL17A gene: The IL17A gene spans a region of 4252 bp composed of three exons (untranslated region (UTR), light blue; coding 
region, blue) and two introns (brown). Exons 1, 2, and 3 are 72 bp (45 bp 5' UTR plus 27 bp coding region), 203 bp (all coding region), and 






Figure 2. A part of the coding sequence of the IL-17A gene in an OLP patient: A, Normal sequencing of exon 1 of IL-17A. B, A 





Polymorphisms of IL-17A, G197A (rs2275913) and IL- 
17F A7488G (p.His161Arg rs763780) have recently been 
identified as being associated with susceptibility to 
rheumatoid arthritis and ulcerative colitis, respectively 
(Nordang et al., 2009; Arisawa et al., 2008). However, 
they have not been investigated with respect to OLP and 
a potential cancer risk. In this study, we investigated the 
IL-17A polymorphisms in relation to the risk of developing 
OLP, whilst further studying the association of each SNP 
with the clinical manifestation of OLP disease  in  patients  
who live in the northwest of Iran. 
The results of our study show that the IL-17A 
polymorphisms in exon 1 were present in only 4.5% for 
T569A and 4.5% for G591A of patients with OLP; a 
percentage slightly higher than that in the control group 
(0%). Within exon 2 of the IL-17A gene, the 
polymorphisms G1776A (p.Arg29Ter rs139620979), 
G1663A and G1578A were seen in OLP patients; in 
contrast, these polymorphisms were not detected in the 
healthy controls. Therefore, the frequencies of these






Figure 3: Normal sequencing of exon 3 of IL-17A gene (A), Sequencing chromatogram 
illustrating the  3566G>GA , c.672 in exon 3 single nucleotide polymorphism 
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Figure 3. Normal sequencing of exon 3 of IL-17A gene (A), sequencing chromatogram illustrating the 3566 G>GA, c.672 in exon 3 




polymorphisms are slightly higher in patients with OLP in 
exon 2 of the IL-17A gene. In addition, we also found that 
the IL-17A G3566A (rs7747909) heterozygote genotype 
was significantly increased in the healthy patients in the 
control group, whereas the IL-17A G3566A (rs7747909) 
homozygote polymorphism was significantly increased in 
exon 3 f the IL-17A gene and were probably associated 
with the development of OLP. 
Recently, association between cytokine gene 
polymorphisms and OLP have been studied. SNPs of IL-
4, IL-6, IL-8, IL-18, tumor necrosis factor A (TNFA), tumor 
necrosis factor receptor 2 (TNFR2) and IFN-α were 
associated with the development of OLP but SNPs of IL-
1, IL-1β, IL-2, IL10, transforming growth factor-beta 1 
(TGF- β1) were not associated with its development. 
(Fujita et al., 2009; Xavier et al., 2007; Bai et al., 2007, 
2008; Dan et al., 2010). 
Our results demonstrate that the frequency of IL-17A 
polymorphisms in cases with OLP and those without OLP 
did not increase with increasing degrees of pain or with 
the number of cigarettes smoked. Smoking habit was not 
shown to be associated with significantly higher number 
of polymorphisms in OLP when comparing long and 
short-term smokers. 
To follow on, association between polymorphisms and 
clinical data of OLP patients were investigated by Xavier 
et al. (2007). Results subsequently showed no 
association between the number of lesions, 
dermatological manifestation or severity of OLP with 
gene polymorphisms IL-1β, IL-6 and IL-10 (Xavier et al., 
2007). 
Finally, the frequencies of the mentioned 
polymorphisms in the genotype (Table 2) were not 
positively associated with OLP, whereas the frequency of 
G3566A (rs7747909) heterozygote genotype was 
reduced. Our results also show no significant variations in 
IL-17A genotype distribution among patients who 
suffered from OLP and the control group. Therefore, 
further studies on a larger population may be needed to 





research may need to focus on identifying novel genetic 
variants and on the interaction of these genetic risk 
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